08045804946
Send Inquiry
LEUXA 22.5 INJ
5000.0 INR/Number
Product Details:
- Indication Treatment of infections caused by susceptible organisms
- Origin of Medicine India
- Salt Composition Ceftriaxone 2000mg + Sulbactam 250mg
- Life Span 24 months
- Brand Name LEUXA 22.5 INJ
- Dosage Form Injection
- Pacakaging (Quantity Per Box) 1 Vial with 10ml Sterile Water for Injection
- Click to View more
X
LEUXA 22.5 INJ Price And Quantity
- 1 Number
- 5000.0 INR/Number
- 2.25 gm (Ceftriaxone 2000mg + Sulbactam 250mg)
- White to pale yellow crystalline powder
- Prescription
- 2 years from manufacturing date
- Intravenous (IV) or Intramuscular (IM)
- Known hypersensitivity to cephalosporins or sulbactam
- Dissolve in 10ml Sterile Water for Injection
- Cephalosporin Antibiotic with Beta-lactamase Inhibitor
- Mild pain at the site of injection, rash, diarrhea, allergic reactions
LEUXA 22.5 INJ Product Specifications
- Antibiotic
- Store in a cool & dry place below 25C. Protect from light.
- Bacterial Infections
- As directed by physician
- Injection
- Ceftriaxone Sodium, Sulbactam Sodium for Injection
- 1 Vial with 10ml Sterile Water for Injection
- Glass Vial with Flip-Off Seal
- Adults, Children
- Ceftriaxone 2000mg + Sulbactam 250mg
- India
- LEUXA 22.5 INJ
- 1 vial
- 24 months
- IV/IM use as per doctors prescription
- Powder for Injection
- Treatment of infections caused by susceptible organisms
- Generic
- 2.25 gm (Ceftriaxone 2000mg + Sulbactam 250mg)
- White to pale yellow crystalline powder
- Prescription
- 2 years from manufacturing date
- Intravenous (IV) or Intramuscular (IM)
- Known hypersensitivity to cephalosporins or sulbactam
- Dissolve in 10ml Sterile Water for Injection
- Cephalosporin Antibiotic with Beta-lactamase Inhibitor
- Mild pain at the site of injection, rash, diarrhea, allergic reactions
LEUXA 22.5 INJ Trade Information
- Cash on Delivery (COD), Cash Advance (CA), Cash in Advance (CID)
- 1000 Number Per Week
- 2 Days
- No
- Asia, Western Europe, Middle East, Africa, Australia, Central America, South America, North America, Eastern Europe
- All India
Product Description
Leuxa 22.5 mg injection is used in both men, women, and children for the following conditions:
- Prostate Cancer (men):It is used for the palliative treatment of advanced prostate cancer by reducing testosterone levels, which helps inhibit tumor growth and ease symptoms like difficulty in urination.
- Hormone-responsive Breast Cancer (women):It can be used to treat certain types of breast cancer in pre/perimenopausal women by lowering estrogen levels.
- Endometriosis (women):By reducing estrogen, it helps shrink the endometrial tissues growing outside the uterus, relieving pain and other symptoms.
- Uterine Fibroids (women):It is used to manage symptoms like heavy bleeding and pelvic pain by reducing the size of non-cancerous growths in the uterus.
- Central Precocious Puberty (children):It delays the onset of early puberty by suppressing the premature release of sex hormones.
Administration and Dosage
The medication is a long-acting (depot) formulation, typically administered as a single injection every three months (12 weeks) either under the skin (subcutaneously) or into a muscle (intramuscularly) by a qualified healthcare professional. It should not be self-administered.
Important Considerations
- Side Effects:Common side effects can include hot flashes, injection site reactions (pain, redness, swelling), fatigue, muscle weakness, headaches, and mood swings.
- Bone Density:Long-term use may lead to decreased bone mineral density; doctors may recommend calcium and vitamin D supplements.
- Pregnancy and Contraception:The injection is contraindicated during pregnancy and breastfeeding as it can harm the fetus. Effective non-hormonal contraception methods must be used by both men and women during treatment to prevent pregnancy.
- Other Conditions:Patients with a history of diabetes, heart conditions, depression, or osteoporosis should use this medication with caution and inform their doctor.
Broad-Spectrum Infection Control
LEUXA 22.5 INJ is designed to treat a variety of bacterial infections by utilizing a synergistic combination of ceftriaxone and sulbactam. This formula efficiently targets organisms that produce beta-lactamase, making it a potent choice for both simple and complicated cases.
Reliable Formulation and Packaging
Each vial contains a precise blend of ceftriaxone and sulbactam in powder form, accompanied by 10ml sterile water for safe and effective reconstitution. The product comes in robust packaging to ensure stability, hygiene, and easy handling in clinical environments.
Safe Usage and Physician Guidance
Usage of LEUXA 22.5 INJ should always be under the supervision of a medical professional. Dosage, route, and duration are tailored to each patient's needs based on the infection's severity and response to treatment, optimizing both efficacy and safety.
FAQ's of LEUXA 22.5 INJ:
Q: How should LEUXA 22.5 INJ be administered?
A: LEUXA 22.5 INJ is intended for intravenous (IV) or intramuscular (IM) injection. The powder should be dissolved in 10ml of sterile water for injection before use, and administration should be carried out by a trained healthcare provider.Q: What infections does LEUXA 22.5 INJ treat?
A: LEUXA 22.5 INJ is recommended for treating a wide range of bacterial infections caused by susceptible organisms, including respiratory, urinary tract, skin, and abdominal infections. It is effective where organisms may be resistant to standard antibiotics.Q: When should LEUXA 22.5 INJ not be used?
A: This medication is contraindicated in patients with known hypersensitivity to cephalosporin antibiotics or sulbactam. Always inform your physician about any allergies prior to starting treatment.Q: What is the process for preparing LEUXA 22.5 INJ for injection?
A: To prepare the injection, dissolve the entire contents of the vial in the provided 10ml sterile water for injection. Mix until completely dissolved, then administer promptly. Only qualified medical personnel should perform the reconstitution and injection.Q: Where should LEUXA 22.5 INJ be stored?
A: LEUXA 22.5 INJ should be stored in a cool and dry place below 25C, protected from light. Ensure it remains out of reach of children and is only used under prescription.Q: What are the possible side effects of using LEUXA 22.5 INJ?
A: Common side effects can include mild pain at the injection site, rash, diarrhea, or allergic reactions. Notify your healthcare provider if you experience any persistent or severe symptoms.Q: What are the benefits of using LEUXA 22.5 INJ over other antibiotics?
A: LEUXA 22.5 INJ combines ceftriaxone's broad-spectrum antibacterial action with sulbactam's beta-lactamase inhibition, offering enhanced effectiveness against resistant bacterial strains for a reliable treatment outcome.Tell us about your requirement
Price:
Quantity
Select Unit
- 50
- 100
- 200
- 250
- 500
- 1000+
Additional detail
Mobile number
Email
Other Products in 'Anti Cancer Medicines' category
Contact Us
- Office No. - 5, Ground Floor, D R Shopping Center, Dattapada Road, Near Hdfc Bank, Borivali East,Mumbai - 400066, Maharashtra, India
- Phone : 08045804946
- Mr Ranjeet Singh (CEO & Founder)
- Mobile : 08045804946
- medisus.pharma007@gmail.com
Send Inquiry
Send SMSMEDISUS PHARMA
All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.
Developed and Managed by Infocom Network Private Limited.
